Global Antenatal Screening Market Size study, By Based on Screening Type (Amniocentesis, Specialist ultrasound, Ultrasound, Chorionic villus sampling), By Based on Indication (Anencephaly, Exomphalos, Gastroschisis, Spina Bifida, Exomphalos, Others), By E

Global Antenatal Screening Market Size study, By Based on Screening Type (Amniocentesis, Specialist ultrasound, Ultrasound, Chorionic villus sampling), By Based on Indication (Anencephaly, Exomphalos, Gastroschisis, Spina Bifida, Exomphalos, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers), and Regional Forecasts 2022-2028

Global Antenatal Screening Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Antenatal screening refers to process of identifying those at high risk of a disorder. Prenatal diagnosis establishes presence of disorder in pregnant women. Antenatal testing helps in evaluating the well-being of the fetus during late pregnancy. It usually involves electronic fetal heart rate monitoring and ultrasound. Rising prevalence of pregnancy complications and increasing awareness towards Antenatal Screening as well as recent favorable government initiatives are key drivers for growth of Antenatal Screening Market. For instance, according to Bill & Melinda Gates Foundation - In 2020, the global maternal mortality ratio was 152 deaths per 100,000 live births, up from 151 deaths per 100,000 live births in 2019 . Furthermore, as per The United Nations Entity for Gender Equality and the Empowerment of Women’s Sustainable Development Goal 3 – UN estimated to reduce the global maternal mortality ratio to less than 70 per 100,000 live births by 2030. Moreover, in March 2020, US-based PerkinElmer selected in Public Health England’s Severe Combined Immunodeficiency (SCID) evaluation programme to provide newborn screening test. This programme is intended for offering newborn screening solutions for detection of a wide range of rare conditions. Also, growing incidences of genetic abnormalities in fetus and increasing healthcare spending are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of awareness towards antenatal screening in emerging countries impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Antenatal Screening Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising awareness towards antenatal screening and rising healthcare spending in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising prevalence of pregnancy complications and growing healthcare sector in the region, would create lucrative growth prospects for the Antenatal Screening Market across the Asia Pacific region.

Major market players included in this report are:
GymnaUniphy N.V.
Biotec Italia srl
Cyronics Instruments Pvt. Ltd
Oakworks Med
India Viking ImpEx Private Ltd
Agilent Technologies Inc
PerkinElmer Inc
GE Healthcare
BGI Genomics Co., Ltd.
Illumina, Inc.


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Based on Screening Type:
Amniocentesis
Specialist ultrasound
Ultrasound
Chorionic villus sampling
By Based on Indication:
Anencephaly
Exomphalos
Gastroschisis
Spina Bifida
Exomphalos
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Antenatal Screening Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



Companies Mentioned

GymnaUniphy N.V.
Biotec Italia srl
Cyronics Instruments Pvt. Ltd
Oakworks Med
India Viking ImpEx Private Ltd
Agilent Technologies Inc
PerkinElmer Inc
GE Healthcare
BGI Genomics Co., Ltd.
Illumina, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.